Patents by Inventor Hong Ding

Hong Ding has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160190178
    Abstract: An array substrate is disclosed. The Array substrate includes gate and data lines, where the gate lines and the data lines cross each other. The pixel units include pixel electrodes and common electrodes, and the common electrode comprises a first slot extending in a direction of the data lines. The first slot at least partially overlaps at least one of the pixel electrodes. In addition, the gate lines each include an aperture region, where the aperture region of each gate line at least partially overlaps at least one of the first slots. Furthermore, shielding electrodes and shielding branch electrodes are provided in the direction of the data lines, where the shielding electrodes at least partially overlap the data lines, and where the shielding branch electrodes are provided in the aperture region, and the shielding branch electrodes at least partially overlap the gate lines.
    Type: Application
    Filed: June 2, 2015
    Publication date: June 30, 2016
    Inventors: Hong DING, Lingxiao DU, Qijun YAO
  • Patent number: 9315488
    Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 or Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which are expressed anti-apoptotic Bcl-2 protein.
    Type: Grant
    Filed: May 29, 2015
    Date of Patent: April 19, 2016
    Assignee: ABBVIE INC.
    Inventors: Hong Ding, Steven W. Elmore, Lisa Hasvold, Laura A. Hexamer, Aaron R. Kunzer, William J. McClellan, Andrew J. Souers, Gerard M. Sullivan, Zhi-Fu Tao, Michael D. Wendt
  • Patent number: 9303025
    Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
    Type: Grant
    Filed: December 23, 2014
    Date of Patent: April 5, 2016
    Assignee: AbbVie Inc.
    Inventors: Milan Bruncko, Hong Ding, George A. Doherty, Steven W. Elmore, Lisa Hasvold, Laura Hexamer, Aaron R. Kunzer, Robert A. Mantei, Cheol-Min Park, Xiaohong Song, Andrew J. Souers, Gerard M. Sullivan, Zhi-Fu Tao, Gary T. Wang, Le Wang, Xilu Wang, Michael D. Wendt
  • Patent number: 9281323
    Abstract: An array substrate is disclosed. The array substrate includes a non-display region surrounding a display region. The array substrate also includes gate lines in the display region, and a gate drive circuit and a bus electrically insulated from the gate lines and a gate drive circuit in the non-display region. The gate lines extend into the non-display region and are electrically connected to the gate drive circuit, and each of the gate lines crosses the bus in a first overlap region. The array substrate also includes auxiliary electrode line segments between the bus and the display region. The auxiliary electrode line segments are electrically insulated from one another and from the gate lines, and the auxiliary electrode line segments are disposed in either of a same conductive layer as the bus, or a layer between the conductive layer of the bus and a conductive layer of the gate lines are disposed.
    Type: Grant
    Filed: May 22, 2014
    Date of Patent: March 8, 2016
    Assignees: Shanghai Tianma Micro-Electronics Co., Ltd., Tianma Micro-Electronics Co., Ltd.
    Inventors: Jian Zhao, Hong Ding
  • Publication number: 20160009687
    Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 or Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which are expressed anti-apoptotic Bcl-2 protein.
    Type: Application
    Filed: May 29, 2015
    Publication date: January 14, 2016
    Inventors: Hong Ding, Steven W. Elmore, Lisa Hasvold, Laura A. Hexamer, Aaron R. Kunzer, William J. McClellan, Gerard M. Sullivan, Andrew J. Souers, Zhi-Fu Tao, Michael D. Wendt
  • Publication number: 20150378589
    Abstract: One aspect is a method for utilizing key points in a progress bar to browse through content. The method includes displaying one or more hill-shaped flags at each of one or more key points on the progress bar such that a hill top of each of the one or more hill-shaped flags corresponds to a respective key point of the one or more key points. The progress bar has a slider configured to slide along the progress bar. The method further includes sliding the slider through a first hill-shaped flag, of the one or more hill-shaped flags, on the progress bar automatically, responsive to browsing content. The method further includes decreasing, by a computer processor, a content browsing speed from a first speed to a second speed, responsive to the slider sliding through the first hill-shaped flag.
    Type: Application
    Filed: June 22, 2015
    Publication date: December 31, 2015
    Inventors: Jian Wen Chi, Run Hua Chi, Zhen Hong Ding, Fang Liang Dong, Chang Lei, Zhao Yang, Wei Jun Zheng
  • Publication number: 20150329541
    Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
    Type: Application
    Filed: April 23, 2015
    Publication date: November 19, 2015
    Inventors: Milan Bruncko, Hong Ding, George A. Doherty, Steven W. Elmore, Lisa A. Hasvold, Laura Hexamer, Aaron R. Kunzer, Xiaohong Song, Andrew J. Souers, Gerard M. Sullivan, Zhi-Fu Tao, Gary T. Wang, Le Wang, Xilu Wang, Michael D. Wendt, Robert Mantei, Todd M. Hansen
  • Patent number: 9174982
    Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
    Type: Grant
    Filed: September 26, 2013
    Date of Patent: November 3, 2015
    Assignees: ABBVIE INC., GENENTECH, INC., THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH
    Inventors: Milan Bruncko, Hong Ding, George A. Doherty, Steven W. Elmore, Lisa A. Hasvold, Laura Hexamer, Aaron R. Kunzer, Xiaohong Song, Andrew J. Souers, Gerard M. Sullivan, Zhi-Fu Tao, Gary T. Wang, Le Wang, Xilu Wang, Michael D. Wendt, Robert A. Mantei, Todd M. Hansen
  • Publication number: 20150279536
    Abstract: The invention is directed to a magnetic chuck and a method for producing a magnetic chuck. The magnetic chuck comprises an upper base made of a single piece of magnetic-conductive material and having a top surface, sidewalls extending orthogonally from the top surface, a cavity formed within the upper base with an open end opposite to the top surface and an opposite closed end directed toward the top surface. A plurality of cores extends orthogonally from the top surface and into the cavity, wherein a plurality of permanent magnets is arranged in the cavity. A reversible magnet is arranged between each of the cores and a lower base; and an excitation coil is arranged around the circumference of each reversible magnet. A portion of the cavity between the permanent magnets and the closed end of the cavity is filled with non-magnetic-conductive material.
    Type: Application
    Filed: March 26, 2015
    Publication date: October 1, 2015
    Inventor: Hong Ding
  • Patent number: 9125913
    Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 or Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which are expressed anti-apoptotic Bcl-2 protein.
    Type: Grant
    Filed: October 18, 2013
    Date of Patent: September 8, 2015
    Assignee: AbbVie Inc.
    Inventors: Milan Bruncko, Hong Ding, George A. Doherty, Steven W. Elmore, Lisa Hasvold, Laura A. Hexamer, Aaron R. Kunzer, Robert A. Mantei, William J. McClellan, Chang H. Park, Cheol-Min Park, Andrew M. Petros, Xiaohong Song, Andrew J. Souers, Gerard M. Sullivan, Zhi-Fu Tao, Gary T. Wang, Le Wang, Xilu Wang, Michael D. Wendt
  • Publication number: 20150240114
    Abstract: A multi-component curable composition which is reactive upon admixing of the components and which is the reaction product of: (i) a polyester epoxy block or graft copolymer having acetoacetoxy functionality; and (ii) a crosslinking component. The crosslinking component may include at least one imine functional compound having an average of at least two imine groups per molecule which are reactive with acetoacetoxy functionality.
    Type: Application
    Filed: May 13, 2015
    Publication date: August 27, 2015
    Applicant: THE SHERWIN-WILLIAMS COMPANY
    Inventors: HONG DING, ZHIQI YANG
  • Patent number: 9072748
    Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 or Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which are expressed anti-apoptotic Bcl-2 protein.
    Type: Grant
    Filed: October 18, 2013
    Date of Patent: July 7, 2015
    Assignee: AbbVie Inc.
    Inventors: Milan Bruncko, Hong Ding, George A. Doherty, Steven W. Elmore, Lisa Hasvold, Laura A. Hexamer, Aaron R. Kunzer, Robert A. Mantei, William J. McClellan, Chang H. Park, Cheol-Min Park, Andrew M. Petros, Xiaohong Song, Andrew J. Souers, Gerard M. Sullivan, Zhi-Fu Tao, Gary T. Wang, Le Wang, Xilu Wang, Michael D. Wendt
  • Publication number: 20150187820
    Abstract: An array substrate is disclosed. The array substrate includes a non-display region surrounding a display region. The array substrate also includes gate lines in the display region, and a gate drive circuit and a bus electrically insulated from the gate lines and a gate drive circuit in the non-display region. The gate lines extend into the non-display region and are electrically connected to the gate drive circuit, and each of the gate lines crosses the bus in a first overlap region. The array substrate also includes auxiliary electrode line segments between the bus and the display region. The auxiliary electrode line segments are electrically insulated from one another and from the gate lines, and the auxiliary electrode line segments are disposed in either of a same conductive layer as the bus, or a layer between the conductive layer of the bus and a conductive layer of the gate lines are disposed.
    Type: Application
    Filed: May 22, 2014
    Publication date: July 2, 2015
    Applicants: Shanghai Tianma Micro Electronics Co., Ltd., Tianma Micro-Electronics Co., Ltd.
    Inventors: Jian ZHAO, Hong Ding
  • Publication number: 20150183775
    Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
    Type: Application
    Filed: December 23, 2014
    Publication date: July 2, 2015
    Inventors: Milan BRUNCKO, Yujia DAI, Hong DING, George A. DOHERTY, Steven W. ELMORE, Lisa HASVOLD, Laura HEXAMER, Aaron R. KUNZER, Robert A. MANTEI, Chang H. PARK, Cheol-Min PARK, Andrew M. PETROS, Xiaohong SONG, Andrew J. SOUERS, Gerard M. SULLIVAN, Zhi-Fu TAO, Gary T. WANG, Le WANG, Xilu WANG, Michael D. WENDT, William J. MCCLELLAN
  • Patent number: 9045444
    Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic protein family members, compositions containing the compounds and uses of the compounds for preparing medicaments for treating diseases during which occurs expression one or more than one of an anti-apoptotic protein family member.
    Type: Grant
    Filed: March 3, 2014
    Date of Patent: June 2, 2015
    Assignee: ABBVIE INC.
    Inventors: Hong Ding, Christopher L. Lynch, Xiaohong Song, Xilu Wang, Michael D. Wendt
  • Patent number: 8952157
    Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
    Type: Grant
    Filed: July 26, 2013
    Date of Patent: February 10, 2015
    Assignees: AbbVie Inc., The Walter and Eliza Hall Institute of Medical Research
    Inventors: Hong Ding, George A. Doherty, Steven W. Elmore, Laura Hexamer, Aaron R. Kunzer, Cheol-Min Park, Xiahong Song, Andrew J. Souers, Gerard M. Sullivan, Zhi-Fu Tao, Le Wang, Michael D. Wendt, Peter Edward Czabotar, Guillaume Laurent Lessene, Peter Malcolm Colman
  • Publication number: 20140302251
    Abstract: A radiation polymerizable aqueous coating composition comprising: (i) ethylenically unsaturated slime treated silica; (ii) at least one water dispersible polyacrylate; (iii) water dispersible ethylenically unsaturated oligomer; and (iv) water.
    Type: Application
    Filed: March 15, 2013
    Publication date: October 9, 2014
    Applicant: THE SHERWIN-WILLIAMS COMPANY
    Inventors: Garry A. Gbur, Hong Ding
  • Patent number: 8853209
    Abstract: Compounds of Formula I wherein A1, B1, C1, D1, E1, F1 and L1 are as defined herein, which inhibit the activity of anti-apoptotic Mcl-1 protein, compositions containing the compounds, and methods of treating diseases involving overexpressed or unregulated Mdl-1 protein, such as leukemia and lymphoma, are disclosed.
    Type: Grant
    Filed: April 15, 2011
    Date of Patent: October 7, 2014
    Assignee: AbbVie Inc.
    Inventors: Xiaohong Song, Hong Ding, Steven W. Elmore, Milan Bruncko, David J. Madar, Andrew J. Souers, Cheol-Min Park, Zhi-Fu Tao, Xilu Wang, Aaron R. Kunzer
  • Publication number: 20140187531
    Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic protein family members, compositions containing the compounds and uses of the compounds for preparing medicaments for treating diseases during which occurs expression one or more than one of an anti-apoptotic protein family member.
    Type: Application
    Filed: March 3, 2014
    Publication date: July 3, 2014
    Applicant: AbbVie Inc.
    Inventors: Milan Bruncko, Hong Ding, Steven W. Elmore, Aaron R. Kunzer, Christopher L. Lynch, William J. McClellan, Cheol-Min Park, Andrew M. Petros, Xiaohong Song, Xilu Wang, Noah P. Tu, Michael D. Wendt, Alexander R. Shoemaker, Michael J. Mitten
  • Patent number: 8757689
    Abstract: The present invention provides a kind of permanent magnetic lifting device, which has: a housing, at the bottom of which is a clamping surface for clamping objects; fixed magnet(s), set in housing relatively fixed to housing; a turnable magnet, set in housing relatively turnable to fixed magnet. When turnable magnet is in the first position relative to fixed magnet, the magnetic force generated by fixed magnet and turnable magnet to clamping surface is zero magnetic force; when turnable magnet is in the third position relative to fixed magnet, the magnetic force generated by fixed magnet and turnable magnet to clamping surface is the maximum magnetic force. The permanent magnetic lifting device also has a positioning mechanism for second position to position the turnable magnet in the second position relative to fixed magnet, fixed magnet and turnable magnet generate trial clamping magnetic force to clamping surface for clamping objects on trial.
    Type: Grant
    Filed: February 12, 2010
    Date of Patent: June 24, 2014
    Assignee: Soph Magnetics (Shanghai) Co., Ltd.
    Inventor: Hong Ding